Mini Review
Patients with COVID-19 may benefit from lung transplantation.
Author(s): Tatiana Williams*
Millions of people have suffered acute lung injury as a result of the COVID-19 epidemic. COVID-related Acute Respiratory Distress Syndrome (CARDS) develops in certain patients, and they are unable to be weaned off of mechanical ventilation. Others may develop post-COVID fibrosis, which can lead to significant impairment and the requirement for long-term oxygen therapy. Treatment teams frequently inquire about lung transplantation in each of these instances. In fact, lung transplantation has been used effectively in a small number of patients globally for both CARDS and post-COVID fibrosis. After a COVID infection, lung transplantation poses a variety of particular issues that transplant teams must consider. The inability to do comprehensive psychosocial evaluation and pre transplantation education in patients with severe CARDS, as well as substantial deconditioning from critical illne.. Read More»
DOI:
10.37532/ pulclr.2022.3(1).3-5
+447723598358
